Fundraising Fox
Rnatives
1 known investors
Find your way into Rnatives
141 people in our graph can introduce you to the Rnatives team.
Sign up to see every warm intro you have to Rnatives
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rnatives team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Develops precision RNA-based gene-regulating therapies aimed at treating serious diseases.
Founders & leadership
TT
Tiia TurunenCDO, Co-founderTiia Turunen is Co-founder and CDO of Rnatives and has a research background in non-coding RNAs and gene expression regulation.
JA
Jeff AbbeyCEOJeff Abbey is CEO of Rnatives and has previously led an oncology cell therapy company through phase 3 clinical development and toward commercialization, with experience raising over $300 million in equity financing and structuring international partnerships and licensing agreements in the biotechnology sector.
Investors · 1
Frequently asked questions
- What does Rnatives do?
- Develops precision RNA-based gene-regulating therapies aimed at treating serious diseases.
- Who founded Rnatives?
- Rnatives was founded by Tiia Turunen.
- Who are Rnatives's investors?
- Rnatives's investors include Nordic Science Investments.